TY  - GEN
AU  - Patti,Francesco
AU  - Chisari,Clara G
AU  - D'Amico,Emanuele
AU  - Zappia,Mario
TI  - Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis
SN  - 1744-7607
PY  - 2018///0309
KW  - Animals
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Biological Availability
KW  - Daclizumab
KW  - Dose-Response Relationship, Drug
KW  - Humans
KW  - Immunoglobulin G
KW  - Immunosuppressive Agents
KW  - Interleukin-2 Receptor alpha Subunit
KW  - immunology
KW  - Magnetic Resonance Imaging
KW  - Medication Adherence
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - drug therapy
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1080/17425255.2018.1432594
ER  -